NORTH READING, MA--(Marketwired - Jul 22, 2015) - TraceLink Inc., the world's largest track and trace network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced that it has added three pharmaceutical industry veterans to the company's growing roster of Life Sciences personnel with deep expertise in product traceability, global serialization, and supply chain transformation. These industry experts are the latest to join the rapidly expanding TraceLink team of 153 employees -- which has increased by more than 80% since January 1, 2015. 

With eight decades of combined experience spanning three of the world's top pharmaceutical brands, the new additions to the TraceLink team include:

  • Michael Ventura, Director Industry Solutions. Ventura joins TraceLink following a 30-year career as the former serialization and security lead for GlaxoSmithKline (GSK) in the Americas, including eight years as an active GS1 Global and GS1 US member, where he currently serves as an elected member of the GS1 US Executive Leadership Team and co-chair of the Traceability Team. While at GSK, he led the company's patient safety and fraud prevention efforts and provided guidance on implementing effective solutions for EMR development, SMS patient authentication, point-of-dispense authentication, and full traceability pilots. In his new role, Ventura will lead strategic discussions with pharmaceutical companies that face significant infrastructure and operational challenges in meeting global track and trace compliance deadlines, and provide practical insight to manufacturers that are working to put successful serialization strategies in place over the next two to three years.
  • Elizabeth Waldorf, Director, Global Traceability. During her 20-year tenure at AMGEN, Waldorf held a range of traceability, supply chain, enterprise architecture and commercial operations roles, where most recently she led the company's global serialization and track and trace initiatives, and drove adoption of GS1 standards across the company. In her new role at TraceLink, Waldorf will develop global regulatory serialization and traceability regulations, and translate them into business and product requirements for TraceLink's portfolio of track and trace solutions. She will also drive standards development within GS1 Global, GS1 US and GS1 Brazil, with active participation in technical and healthcare workgroups to apply the GS1 EPCIS standard towards meeting country level track and trace requirements. Waldorf is currently a co-chair for the GS1 Brazil working group that is focused on developing traceability and serialization guidelines for the country.
  • Marcel Zutter, Senior Implementation Program Manager, EMEA. Zutter is a 30-year pharmaceutical industry veteran with decades of transformational experience in supply chain systems and process management. In his most recent position at Abbott, he served as the global serialization and track and trace program-lead for the company's Established Pharmaceuticals Division. Now, as part of TraceLink's Professional Services team, Marcel will leverage his deep knowledge of implementing traceability programs on the manufacturing side to help TraceLink customers in EMEA carefully plan and execute successful serialization strategies to achieve regional and global compliance.

"A core component of our growth strategy is to build an organization with deeper domain expertise than any other track and trace solution provider," said Shabbir Dahod, president and CEO of TraceLink. "The eight decades of combined pharmaceutical expertise that Michael, Elizabeth and Marcel bring to TraceLink adds to the vast knowledgebase we've been building that includes tenured professionals who have dedicated their careers to solving complex traceability challenges in Life Sciences. No other solutions provider can outpace the stable of domain experts that we're assembling at TraceLink, and our commitment to serve the Life Sciences industry with talent that comes directly from the industry itself."

To learn more about TraceLink, the Life Sciences Cloud or how to build a flexible, cost-effective global serialization, track and trace, and reporting platform, visit

About TraceLink
TraceLink protects patients, enables health and ensures compliance for companies across the global Life Sciences supply network, including 16 of the top-20 global pharmaceutical companies. Leading businesses trust the TraceLink Life Sciences Cloud, our Amazon AWS-based cloud application platform, to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit or follow us on LinkedIn, Twitter and Facebook.

TraceLink is funded by FirstMark Capital, Volition Capital and Fidelity Biosciences.

Contact Information:

Media Contact:
Laura MacSweeney
Red Javelin Communications
(781) 395-6420